[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sera Prognostics Inc Cl A (SERA)

Sera Prognostics Inc Cl A (SERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 79,493
  • Shares Outstanding, K 39,159
  • Annual Sales, $ 80 K
  • Annual Income, $ -31,930 K
  • EBIT $ -37 M
  • EBITDA $ -36 M
  • 60-Month Beta 0.97
  • Price/Sales 879.87
  • Price/Cash Flow N/A
  • Price/Book 1.05

Options Overview Details

View History
  • Implied Volatility 118.01% (-274.87%)
  • Historical Volatility 77.81%
  • IV Percentile 9%
  • IV Rank 17.03%
  • IV High 557.72% on 04/02/26
  • IV Low 27.74% on 09/03/25
  • Expected Move (DTE 15) 0.17 (8.50%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 4
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 451
  • Open Int (30-Day) 449
  • Expected Range 1.83 to 2.17

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.14
  • Number of Estimates 1
  • High Estimate $-0.14
  • Low Estimate $-0.14
  • Prior Year $-0.16
  • Growth Rate Est. (year over year) +12.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.73 +15.94%
on 06/22/26
2.33 -14.16%
on 06/05/26
-0.04 (-1.96%)
since 06/02/26
3-Month
1.56 +28.21%
on 05/14/26
2.37 -15.61%
on 05/26/26
-0.01 (-0.50%)
since 04/02/26
52-Week
1.56 +28.21%
on 05/14/26
3.95 -49.37%
on 10/27/25
-0.45 (-18.37%)
since 07/02/25

Most Recent Stories

More News
SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS

SALT LAKE CITY , June 30, 2026 /PRNewswire/ -- Sera Prognostics Inc. , The Pregnancy Company ® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...

SERA : 2.00 (-1.48%)
SERA PROGNOSTICS COLLABORATES ON ARPA-H AWARD TO ADVANCE POINT-OF-CARE DIAGNOSTIC FOR SAFER BIRTH

SALT LAKE CITY , June 24, 2026 /PRNewswire/ -- Sera Prognostics Inc. , The Pregnancy Company ® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...

SERA : 2.00 (-1.48%)
SERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCY

--Aligns With Growing Focus on Early Identification and Management of Preterm Birth Risk--

SERA : 2.00 (-1.48%)
SERA PROGNOSTICS ANNOUNCES BOARD TRANSITION

SALT LAKE CITY , June 1, 2026 /PRNewswire/ --  Sera Prognostics Inc. , The Pregnancy Company ® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative...

SERA : 2.00 (-1.48%)
SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FIRST QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON MAY 6, 2026

SALT LAKE CITY , April 22, 2026 /PRNewswire/ -- Sera Prognostics Inc. , The Pregnancy Company ® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative...

SERA : 2.00 (-1.48%)
SERA PROGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS

SALT LAKE CITY , March 18, 2026 /PRNewswire/ --  Sera Prognostics Inc. , The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...

SERA : 2.00 (-1.48%)
SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FOURTH QUARTER AND FISCAL YEAR 2025 FINANCIAL RESULTS ON MARCH 18, 2026

SALT LAKE CITY , March 4, 2026 /PRNewswire/ -- Sera Prognostics Inc. , The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...

SERA : 2.00 (-1.48%)
SERA PROGNOSTICS TO PRESENT AT TD COWEN 46th ANNUAL HEALTH CARE CONFERENCE

SALT LAKE CITY , Feb. 17, 2026 /PRNewswire/ -- Sera Prognostics Inc. , The Pregnancy Company ® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...

SERA : 2.00 (-1.48%)
Landmark Study Finds PreTRM® Blood Test Reduces Earliest Preterm Births and Newborn Complications

Published in the journal PREGNANCY, the PRIME Study demonstrates significant improvements in neonatal outcomes with early risk screening and targeted interventions.

SERA : 2.00 (-1.48%)
Sera Announces Publication Acceptance for PRIME Study

The PRIME study, one of the largest studies on preterm birth, has been accepted for publication by a medical journal following abstract presentation earlier this year

SERA : 2.00 (-1.48%)

Business Summary

Sera Prognostics Inc. is a women's health diagnostics company. It focused on improving maternal and neonatal health by providing pregnancy biomarker information to doctors and patients. Sera Prognostics Inc. is based in SALT LAKE CITY.

See More

Key Turning Points

3rd Resistance Point 2.22
2nd Resistance Point 2.15
1st Resistance Point 2.08
Last Price 2.00
1st Support Level 1.94
2nd Support Level 1.87
3rd Support Level 1.80

See More

52-Week High 3.95
Fibonacci 61.8% 3.04
Fibonacci 50% 2.76
Fibonacci 38.2% 2.47
Last Price 2.00
52-Week Low 1.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.